1 of 1
Story summary
- Sen. Jeanne Shaheen (D-N.H.) is urging Senate leadership to schedule a floor vote on bipartisan insulin-cost-cap legislation.
- She wants the bill passed before the end of 2026.
- The bill caps commercial insulin out-of-pocket costs at $35 and expands the Medicare cap.
- The Senate HELP Committee approved the measure 17-5 in July.